Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers

Tefibazumab (Aurexis) is a humanized monoclonal antibody being evaluated as adjunctive therapy for the treatment of Staphylococcus aureus infections. This open-label, dose escalation study evaluated the safety and pharmacokinetics of tefibazumab in 19 healthy volunteers aged 18 to 69 years. Each sub...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Reilley, Sandra, Wenzel, Eric, Reynolds, Laurie, Bennett, Beth, Patti, Joseph M., Hetherington, Seth
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2005
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC549258/
https://ncbi.nlm.nih.gov/pubmed/15728889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.3.959-962.2005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky